益方生物-U
(688382)
| 流通市值：154.18亿 | | | 总市值：213.52亿 |
| 流通股本：4.18亿 | | | 总股本：5.78亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 19,163,847.37 | 8,188,968.92 | 168,790,397.56 | 19,156,299.24 |
| 营业收入 | 19,163,847.37 | 8,188,968.92 | 168,790,397.56 | 19,156,299.24 |
| 二、营业总成本 | 131,684,739.5 | 65,993,855.34 | 410,066,940.31 | 327,620,052.49 |
| 营业成本 | 2,486,836.43 | 1,155,320.93 | 3,923,936.17 | 7,031,049.1 |
| 税金及附加 | 58,725.22 | 41,492.19 | 91,684.39 | 70,907.64 |
| 管理费用 | 22,048,832.54 | 10,411,126.76 | 52,499,006.25 | 43,184,858.85 |
| 研发费用 | 115,458,842.89 | 60,674,466.51 | 384,347,004.37 | 295,676,116.12 |
| 财务费用 | -8,368,497.58 | -6,288,551.05 | -30,794,690.87 | -18,342,879.22 |
| 其中:利息费用 | - | 283,229.3 | 664,547.13 | - |
| 其中:利息收入 | -9,163,267.67 | -6,762,697.62 | 30,021,315.36 | -19,712,098.72 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 886,746.71 | 530,000 | 1,300,000 | 830,000 |
| 加:投资收益 | 84,099.81 | - | - | - |
| 资产处置收益 | - | - | 75,015.44 | - |
| 信用减值损失(新) | -16,499,814.5 | -411,564 | -8,868,360.43 | -4,749,397.83 |
| 其他收益 | 8,617,380.26 | 187,380.26 | 8,566,042.88 | 7,076,641.36 |
| 四、营业利润 | -119,432,479.85 | -57,499,070.16 | -240,203,844.86 | -305,306,509.72 |
| 五、利润总额 | -119,432,479.85 | -57,499,070.16 | -240,203,844.86 | -305,306,509.72 |
| 六、净利润 | -119,432,479.85 | -57,499,070.16 | -240,203,844.86 | -305,306,509.72 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -119,432,479.85 | -57,499,070.16 | -240,203,844.86 | -305,306,509.72 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -119,432,479.85 | -57,499,070.16 | -240,203,844.86 | -305,306,509.72 |
| 扣除非经常损益后的净利润 | -129,020,706.63 | -58,216,450.42 | -250,144,903.18 | -313,213,151.08 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.21 | -0.1 | -0.42 | -0.53 |
| (二)稀释每股收益 | -0.21 | -0.1 | -0.42 | -0.53 |
| 八、其他综合收益 | -463,965.38 | -502,494.69 | -1,159,124.87 | -1,629,834.88 |
| 归属于母公司股东的其他综合收益 | -463,965.38 | -502,494.69 | -1,159,124.87 | -1,629,834.88 |
| 九、综合收益总额 | -119,896,445.23 | -58,001,564.85 | -241,362,969.73 | -306,936,344.6 |
| 归属于母公司股东的综合收益总额 | -119,896,445.23 | -58,001,564.85 | -241,362,969.73 | -306,936,344.6 |
| 公告日期 | 2025-08-23 | 2025-04-29 | 2025-04-26 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |